BOI:EPA
Boiron SA
20,00 €
arrow_upward
+0,50%(+0,10) 1D
10 қар., 09:31:31 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Open
20,00 €
High
20,30 €
Low
20,00 €
Mkt. cap
350,91 млн
Avg. vol.
5,03 мың
Volume
205,00
P/E ratio
13,26
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 мың
Open
20,00 €
High
20,30 €
Low
20,00 €
Mkt. cap
350,91 млн
Avg. vol.
5,03 мың
Volume
205,00
P/E ratio
13,26
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 мың
News stories
From web sources and news partners
FXStreet
·
11 минут бұрын
S&P 500: Tech rebound drives strong gains – Deutsche Bank
Trefis
·
2 сағат бұрын
S&P 500 Stocks At 52-Week Lows: Monday’s Full List
Investing.com
·
1 сағат бұрын
S&P 500 Got Its Bounce - Now Comes The Hard Part
Bloomberg.com
·
1 күн бұрын
Watch 95% S&P 500, 5% Bitcoin in New Franklin ETF: Drilldown
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron SA
CEO-
Employees2,62 мың
Founded1932 ж. 07 мау.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr